5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2,4-dione
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2,4-dione

● In Stock

Catalogue No.:VE0021563
CAS No.:N/A
Mol. Formula:C10H16O4
Mol. Weight:489.63 g/mol

Additional information on 5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2 | 4-dione

Parent drug

Pioglitazone

IUPAC Name

5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2, 4-dione

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

CCC1=CN=C(CCOC2=CC=C(CC3C(N(CCC4=NC=C(CC)C=C4)C(S3)=O)=O)C=C2)C=C1

InChI

InChI=1S/C28H31N3O3S/c1-3-20-5-9-23(29-18-20)13-15-31-27(32)26(35-28(31)33)17-22-7-11-25(12-8-22)34-16-14-24-10-6-21(4-2)19-30-24/h5-12, 18-19, 26H, 3-4, 13-17H2, 1-2H3

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Description

The compound 5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2 | 4-dione is a highly characterized reference material that meets stringent regulatory standards | including those set by USP | EMA | JP | and BP. This product is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Pioglitazone production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally | the product comes with a detailed Structure Elucidation Report (SER) | ensuring its precision and reliability for comprehensive analytical use.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form